Iridian Asset Management LLC Axsome Therapeutics, Inc. Call Options Transaction History

Iridian Asset Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 10, 2021	SELL	$19.91 - $68.26 $149,325 - $511,950	-7,500 Reduced 33.33%	15,000 $494,000
Q2 2021 Aug 11, 2021	BUY	$50.63 - $73.5 $977,159 - $1.42 Million	19,300 Added 603.13%	22,500 $1.52 Million
Q1 2021 May 11, 2021	SELL	$55.91 - $81.44 $391,370 - $570,080	-7,000 Reduced 68.63%	3,200 $181,000
Q1 2020 May 11, 2020	BUY	$41.2 - $101.31 $420,240 - $1.03 Million	10,200 New	10,200 $600,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Iridian Asset Management LLC with notifications on news.